From discovery to pre-validated and custom multiplexed biomarker panels for proteins, PTMs, lipids, metabolites, and more.
Accelerate drug discovery and development pipelines utilizing our CLIA, FDA inspected (US) and GCP/GLP (UK) certified labs.
Find and understand the biochemical interactions that matter.
De-risk clinical trials by enrolling the strongest patient responders to treatment.
Develop a pre-clinical biomarker strategy that can be translated into treatment monitoring and a CDx during clinical trials.
How mass spectrometry identifies and quantifies protein abundance
50+ biomarkers multiplexed in a single run, with no cross-reactivity
Fully quantitative
All targets fully calibrated and validated
Custom assays to fit your unique biomarker needs
Rapid development
End-to-end service from biomarker selection to analysis and reporting
Data-independent acquisition (DIA) insights over thousands of samples
Matrix independent analysis designed for multiple sample types
Comprehensive & accessible results
Proteomics in three easy steps, tailored to your needs
Select from our pre-validated panels or
work with our Proteomics Experts to create a custom panel.
Don’t know what needs to be monitored? Reach out to begin your discovery proteomics project
For custom panels, we design and validate the assay to meet your specifications including regulatory submissions.
Results are returned within 2 months for pre-validated panels, and 3 – 4 months for custom assays, in a detailed yet concise format that ties your data to the relevant biology.
We’re available to answer any questions and consult on next steps.
Our global network of high-throughput labs feature the most advanced mass spectrometry technology, enabling multiple samples to be analyzed daily
Don’t miss out on this limited-time opportunity to gain a competitive edge and achieve groundbreaking discoveries. Please fill out this form to access the MasterKey™ catalog.
Please fill out this form to access the MasterKey™ catalog and to stay updated with newly added proteins
Please fill out the form to subscribe to our newsletter.